Effects of thymoquinone and memantine alone and in combination on memory and hippocampal morphology in rats with streptozotocin-induced Alzheimer's disease.
Alzheimer's disease
memantine
streptozotocin
thymoquinone
Journal
Turkish journal of medical sciences
ISSN: 1303-6165
Titre abrégé: Turk J Med Sci
Pays: Turkey
ID NLM: 9441758
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
31
01
2023
accepted:
25
05
2023
medline:
1
12
2023
pubmed:
30
11
2023
entrez:
30
11
2023
Statut:
ppublish
Résumé
Alzheimer's disease (AD) is a progressive neurodegenerative disease. Thymoquinone (TQ) has broad biological functions, including antiinflammatory, antioxidant, neuroprotective properties. Memantine (MEM) is indicated for the symptomatic treatment of moderate to severe AD. We aimed to evaluate the effect of TQ alone or in combination with MEM on memory and hippocampal morphology in an STZ-induced rat AD model. Thirty male rats were included in this study. The AD model was created by giving ICV STZ. The rats were divided into 5 groups (n = 6 each). Group 1 (control group): The rats received only ICV-STZ 3 mg/kg for 2 weeks. Group 2 (sham group): In addition to ICV STZ, 9% NaCl, 1 mL/day i.p. for 2 weeks of injection, was applied. Group 3 (TQ group): In addition to ICV STZ, rats received TQ 10 mg/kg i.p. for 2 weeks. Group 4 (MEM group): In addition to ICV STZ, rats were given MEM at a dose of 5 mg/kg for two weeks. Group 5 (TQ+MEM group): In addition to ICV STZ, this group was given TQ (10 mg/kg/day, i.p.) and MEM (5 mg/kg/day, i.p.) for 2 weeks. On the 15th day, passive avoidance learning (PAL) was applied to all groups. Then, rats were sacrificed, neurons in the hippocampal CA1, CA2, CA3 regions were evaluated. Groups 3, 4, 5 had longer latency periods than groups 1 and 2. The neuron density in the CA1, CA2, CA3 regions had decreased in groups 1 and 2 compared to groups 3, 4, 5. There were significantly more neurons in groups 3, 4, 5 than in groups 1 and 2. We found that TQ alone and in combination with MEM showed ameliorative effects on memory and hippocampal morphology. TQ may offer a promising treatment strategy for AD.
Sections du résumé
BACKGROUND
BACKGROUND
Alzheimer's disease (AD) is a progressive neurodegenerative disease. Thymoquinone (TQ) has broad biological functions, including antiinflammatory, antioxidant, neuroprotective properties. Memantine (MEM) is indicated for the symptomatic treatment of moderate to severe AD. We aimed to evaluate the effect of TQ alone or in combination with MEM on memory and hippocampal morphology in an STZ-induced rat AD model.
METHODS
METHODS
Thirty male rats were included in this study. The AD model was created by giving ICV STZ. The rats were divided into 5 groups (n = 6 each). Group 1 (control group): The rats received only ICV-STZ 3 mg/kg for 2 weeks. Group 2 (sham group): In addition to ICV STZ, 9% NaCl, 1 mL/day i.p. for 2 weeks of injection, was applied. Group 3 (TQ group): In addition to ICV STZ, rats received TQ 10 mg/kg i.p. for 2 weeks. Group 4 (MEM group): In addition to ICV STZ, rats were given MEM at a dose of 5 mg/kg for two weeks. Group 5 (TQ+MEM group): In addition to ICV STZ, this group was given TQ (10 mg/kg/day, i.p.) and MEM (5 mg/kg/day, i.p.) for 2 weeks. On the 15th day, passive avoidance learning (PAL) was applied to all groups. Then, rats were sacrificed, neurons in the hippocampal CA1, CA2, CA3 regions were evaluated.
RESULTS
RESULTS
Groups 3, 4, 5 had longer latency periods than groups 1 and 2. The neuron density in the CA1, CA2, CA3 regions had decreased in groups 1 and 2 compared to groups 3, 4, 5. There were significantly more neurons in groups 3, 4, 5 than in groups 1 and 2.
DISCUSSION
CONCLUSIONS
We found that TQ alone and in combination with MEM showed ameliorative effects on memory and hippocampal morphology. TQ may offer a promising treatment strategy for AD.
Identifiants
pubmed: 38031940
doi: 10.55730/1300-0144.5653
doi:
Substances chimiques
Memantine
W8O17SJF3T
Streptozocin
5W494URQ81
thymoquinone
O60IE26NUF
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
894-901Références
Mount C, Downton C. Alzheimer disease: progress or profit. Nature Medicine 2006; 12: 780-784. https://
doi: 10.1038/nm0706-780
Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA et al. Alzheimer’s disease. Nature Reviews Disease Primers 2015; 1: 15056. https://
doi: 10.1038/nrdp.2015.56
Mufson EJ, Mahady L, Waters D, Counts SE, Perez SE et al. Hippocampal plasticity during the progression of alzheimer’s disease. Neuroscience 2015; 309: 51-67. https://
doi: 10.1016/j.neuroscience.2015.03.006
Liu J, Chang L, Song Y, Li H, Wu Y. The role of NMDA receptors in alzheimer’s disease. Front Neuroscience 2019; 13: 43. https://
doi: 10.3389/fnins.2019.00043
Murakawa-Hirachi T, Mizoguchi Y, Ohgidani M, Haraguchi Y, Monji A. Effect of memantine, an anti-Alzheimer’s drug, on rodent microglial cells in vitro. Scientific Reports 2021; 11: 6151. https://
doi: 10.1038/s41598-021-85625-4
McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database of Systematic Reviews 2006; 2: CD003154. https://
doi: 10.1002/14651858.CD003154.pub5
Shao Y, Feng Y, Xie Y, Luo Q, Chen L et al. Protective effects of thymoquinone against convulsant activity induced by lithiumpilocarpine in a model of status epilepticus. Neurochem Research 2016; 41 (12): 3399-3406. https://
doi: 10.1007/s11064-016-2074-y
Abulfadl YS, El-Maraghy NN, Ahmed AE, Nofal S, AbdelMottaleb Y et al. Thymoquinone alleviates the experimentally induced Alzheimer’s disease inflammation by modulation of TLRs signaling. Human and Experimental Toxicology 2018; 37 (10): 1092-1104. https://
doi: 10.1177/0960327118755256
Anaeigoudari A, Norouzi F, Abareshi A, Beheshti F, Aaghaei A, Shafei MN et al. Protective effects of nigella sativa on synaptic plasticity impairment induced by lipopolysaccharide. Veterinary Research Forum 2018; 9: 27-33.
doi: PMCID:PMC5913558
Sayeed MS, Asaduzzaman M, Morshed H, Hossain MM, Kadir MF et al. The effect of nigella sativa linn. seed on memory, attention and cognition in healthy human volunteers. Journal of Ethnopharmacol 2013; 148 (3): 780-786. https://
doi: 10.1016/j.jep.2013.05.004
Sahak MK, Kabir N, Abbas G, Draman S, Hashim NH et al. The role of nigella sativa and its active constituents in learning and memory. Evidence-Based Complementary and Alternative Medicine 2016; 6075679. https://
doi: 10.1155/2016/6075679
Kamat PK. Streptozotocin induced alzheimer’s disease like changes and the underlying neural degeneration and regeneration mechanism. Neural Regeneration Research 2015; 10 (7): 1050-1052. https://
doi: 10.4103/1673-5374.160076
Rostami F, Javan M, Moghimi A, Haddad-Mashadrizeh A, Fereidoni M. Streptozotocin-induced hippocampal astrogliosis and insulin signaling malfunction as experimental scales for subclinical sporadic alzheimer model. Life Sciences 2017; 188: 172-185. https://
doi: 10.1016/j.lfs.2017.08.025
Mehri S, Shahi M, Razavi BM, Hassani FV, Hosseinzadeh H. Neuroprotective effect of thymoquinone in acrylamideinduced neurotoxicity in wistar rats. Iranian Journal of Basic Medical Sciences 2014; 17 (12): 1007-11.
doi: PMCID:PMC4387223
Sedaghat R, Roghani M, Khalili M. Neuroprotective effect of thymoquinone, the nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model. Iranian Journal of Pharmaceutical Research 2014; 13 (1): 227- 34.
doi: PMCID:PMC3985249
Motawaj M, Burban A, Davenas E, Arrang JM. Activation of brain histaminergic neurotransmission: a mechanism for cognitive effects of memantine in alzheimer’s disease. Journal of Pharmacology and Experimental Therapeutics 2011; 336 (2): 479-487. https://
doi: 10.1124/jpet.110.174458
Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Spiral Bound, 4th ed. New York: Academic Press 1998.
Erbaş O, Solmaz V, Aksoy D, Yavaşoğlu A, Sağcan M, Taşkıran D. Cholecalciferol (vitamin D 3) improves cognitive dysfunction and reduces inflammation in a rat fatty liver model of metabolic syndrome. Life Sciences 2014; 103 (2): 68- 72. https://
doi: 10.1016/j.lfs.2014.03.035
Erbaş O, Erdoğan MA, Khalilnezhad A, Solmaz V, Gürkan FT et al. Evaluation of long-term effects of artificial sweeteners on rat brain: a biochemical, behavioral, and histological study Journal of Biochemical and Molecular Toxicology 2018; 32 (6): e22053. https://
doi: 10.1002/jbt.22053
İlhan A, Gürel A, Armutçu F, Kamışlı S, Iraz M et al. Ginkgo biloba prevents mobile phone-induced oxidative stress in rat brain. Clinica Chimica Acta 2004; 340 (1-2): 153-162. https://
doi: 10.1016/j.cccn.2003.10.012
Rizzi L, Rosset I, Roriz-Cruz M. Global epidemiology of dementia: Alzheimer’s and vascular types. BioMed esearch International 2014; Article 908915. https://
doi: 10.1155/2014/908915
Mayeux R, Stern Y. Epidemiology of alzheimer disease. Cold Spring Harbor Perspectives in Medicine 2012; 2 (8): a006239. https://
doi: 10.1101/cshperspect.a006239
Parsons CG, Stoffler A, Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse. Neuropharmacology 2007; 53 (6): 699-723. https://
doi: 10.1016/j.neuropharm.2007.07.013
Kutzing MK, Luo V, Firestein BL. Protection from glutamateinduced excitotoxicity by memantine. Annals of Biomedical Engineering 2012; 40 (5): 1170-1181. https://
doi: 10.1007/s10439-011-0494-z
Weller M, Marini AM, Finiels-Marlier F, Martin B, Paul SM. MK-801 and memantine protect cultured neurons from glutamate toxicity induced by glutamate carboxypeptidasemediated cleavage of methotrexate. European Journal of Pharmacology 1993; 248 (4): 303-312.
doi: 10.1016/0926-6917(93)90004-A
Van Dam D, De Deyn PP. Cognitive evaluation of diseasemodifying efficacy of galantamine and memantine in the APP23 model. European Neuropsychopharmacoly 2006; 16 (1): 59-69. https://
doi: 10.1016/j.euroneuro.2005.06.005
Miguel-Hidalgo JJ, Alvarez XA, Cacabelos R, Quack G. Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40). Brain Research 2002; 958 (1): 210-221. https://
doi: 10.1016/s0006-8993(02)03731-9
Guerrero-Muñoz MJ, Gerson J, Castillo-Carranza DL. Tau oligomers: The toxic player at synapses in alzheimer’s disease. Frontiers in Cellular Neuroscience 2015; 9: 464.
doi: 10.3389/fncel.2015.00464
Danysz W, Parsons CG. Alzheimer’s disease, β-amyloid, glutamate, NMDA receptors and memantine searching for the connections. British Journal of Pharmacology 2012; 167; 324- 352. https://
doi: 10.1111/j.1476-5381.2012.02057.x
Stazi M, Wirths O. Chronic memantine treatment ameliorates behavioral deficits, neuron loss, and impaired neurogenesis in a model of alzheimer’s disease. Molecular Neurobiology 2021; 58: 204-216. https://
doi: 10.1007/s12035-020-02120-z
Matsunaga S, Kishi T, Iwata N. Memantine monotherapy for alzheimer’s disease: A systematic review and meta-analysis. PLoS One 2015; 10 (4): e0123289. https://
doi: 10.1371/journal.pone.0123289
Keilhoff G, Wolf G. Memantine prevents quinolinic acidinduced hippocampal damage. European Journal of Pharmacology 1992; 219 (3): 451-454. https://
doi: 10.1016/0014-2999(92)90487-o
Miguel-Hidalgo JJ, Alvarez XA, Cacabelos R, Quack G. Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40). Brain Research 2002; 958 (1): 210-221. https://
doi: 10.1016/s0006-8993(02)03731-9
Farkhondeh T, Samarghandian S, Shahri AMP, Samini F. The neuroprotective effects of thymoquinone: A review. Dose Response 2018; 16 (2): 1559325818761455. https://
doi: 10.1177/1559325818761455
Sanati AR, Farkhondeh T, Samarghandian S. Antidotal effects of thymoquinone against neurotoxic agents. Interdisciplinary Toxicology 2018; 11 (2): 122-128. https://
doi: 10.2478/intox-2018-0008
Chen Z, Zhong C. Oxidative stress in alzheimer’s disease. Neuroscience Bulletin 2014; 30: 271-281. https://
doi: 10.1007/s12264-013-1423-y
Imam A, Ajao MS, Ajibola MI, Amin A, Abdulmajeed WI et al. Black seed oil ameliorated scopolamine-induced memory dysfunction and cortico-hippocampal neural alterations in male wistar rats. Bulletin of Faculty of Pharmacy, Cairo University 2016; 54: 49-57. https://
doi: 10.1016/j.bfopcu.2015.12.005
Alhebshi A, Gotoh M, Suzuki I. Thymoquinone protects cultured rat primary neurons against amyloid β-induced neurotoxicity. Biochemical and Biophysical Research Communications 2013; 433 (4): 362-367. https://
doi: 10.1016/j.bbrc.2012.11.139
Elibol B Terzioglu-Usak S, Beker M, Sahbaz C. Thymoquinone (TQ) demonstrates its neuroprotective effect via an anti-inflammatory action on the Aβ (1–42)-infused rat model of alzheimer’s disease. Psychiatry and Clinical Psychopharmacology 2019; 29 (4): 379-386.
doi: 10.1080/24750573.2019.1673945
Baghcheghi Y, Hosseini M, Beheshti F, Salmani H, Anaeigoudari A. Thymoquinone reverses learning and memory impairments and brain tissue oxidative damage in hypothyroid juvenile rats. Arquivos de Neuro-Psiquiatria 2018; 76 (1): 32-40. https://
doi: 10.1590/0004-282X20170182
Kanter M. Nigella sativa and derived thymoquinone prevents hippocampal neurodegeneration after chronic toluene exposure in rats. Neurochemical Research 2008; 33 (3): 579-588. https://
doi: 10.1007/s11064-007-9481-z
Hajipour S, Sarkaki A, Dianat M, Rashno M, Khorsandi LS et al. The effects of thymoquinone on memory impairment and inflammation in rats with hepatic encephalopathy induced by thioacetamide. Metabolic Brain Disease 2021; 36 (5): 991-1002. https://
doi: 10.1007/s11011-021-00688-6
Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A et al. Hippocampus and its involvement in alzheimer’s disease: a review. 3 Biotech 2022; 12 (2): 55. https://
doi: 10.1007/s13205-022-03123-4
De Flores R, La Joie R, Chételat G. Structural imaging of hippocampal subfields in healthy aging and alzheimer’s disease. Neuroscience 2015; 309: 29-50. https://
doi: 10.1016/j.neuroscience.2015.08.033
Simić G, Kostović I, Winblad B, Bogdanović N. Volume and number of neurons of the human hippocampal formation in normal aging and alzheimer’s disease. The Journal of Comparative Neurology 1997; 379 (4): 482-494. https://
doi: 10.1002/(sici)1096-9861(19970324)379:4<482::aidcne2>3.0.co;2-z
Kril JJ, Hodges J, Halliday G. Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without alzheimer’s disease. Neuroscience Letters 2004; 361 (1- 3): 9-12. https://
doi: 10.1016/j.neulet.2004.02.001